Panelists discuss how managing advanced polycythemia vera requires tailored approaches beyond hydroxyurea when patients show resistance (persistent hematocrit >45%, elevated white blood cell counts, ...

Panelists discuss how polycythemia vera treatment follows a risk-stratified approach, with all patients receiving daily aspirin and phlebotomies to maintain hematocrit below 45%, while high-risk ...

Published Research Demonstrates the Value of BVA in Meeting Key Goal of Identifying Anemia in Heart Failure Patients Oak ...

Q1 2025 Earnings Call Transcript May 13, 2025 Operator: Good day, everyone, and welcome to Nuwellis First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only ...

Join Parachute implementing Terumo Blood and Cell Technologies’ Rika Plasma Donation System to enhance donor experience and help expand access to lifesaving therapies Lakewood, Colorado, May 12, 2025 ...

Machine learning identifies key biomarkers predicting hydroxyurea resistance in polycythemia vera, enhancing early treatment ...

Genetic adaptation and physiological changes among South Korea's Haenyeo divers revealed in groundbreaking study.

According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among ...

Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1stConference call ...

Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1stConference call t ...

Scientists from Saratov State Medical University have developed a mini-laboratory for non-invasive blood analysis. According to the developers, this portable device will allow emergency physicians and ...